Summary
E.I. du Pont de Nemours and Company (DuPont) filed its 2016 10-K report on February 1, 2017, detailing its business operations, financial condition, and significant upcoming strategic initiatives. The most impactful development highlighted is the impending merger of equals with The Dow Chemical Company (Dow), a transaction expected to close in the first half of 2017. Following the merger, the combined entity, DowDuPont, plans to separate into three independent, publicly traded companies focused on agriculture, material science, and specialty products. This transformative event is central to the company's future, though it introduces significant integration risks and regulatory hurdles. Operationally, DuPont reported stable net sales for 2016, with slight decreases attributed to currency fluctuations and pricing. The company has actively pursued cost-saving initiatives, including a 2016 global cost savings and restructuring plan that delivered targeted reductions. DuPont operates across six key segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials, and Protection Solutions, with a significant portion of its sales derived internationally. The company's R&D investment remains substantial, underscoring its commitment to innovation. Investors should note the company's ongoing efforts to streamline its operations and portfolio, including the prior spin-off of its Performance Chemicals segment (Chemours). While financial performance shows resilience, the near-term outlook is heavily influenced by the successful integration of the Dow merger and subsequent intended separations. Key risks include regulatory approval delays, integration challenges, and potential impacts on customer and supplier relationships.
Financial Highlights
56 data points| Revenue | $24.59B |
| Cost of Revenue | $14.47B |
| Gross Profit | $10.13B |
| R&D Expenses | $1.64B |
| SG&A Expenses | $4.32B |
| Operating Income | $2.51B |
| Interest Expense | $370.00M |
| Net Income | $2.52B |
| EPS (Basic) | $2.87 |
| EPS (Diluted) | $2.85 |
| Shares Outstanding (Basic) | 872.56M |
| Shares Outstanding (Diluted) | 877.04M |
Key Highlights
- 1Impending merger of equals with The Dow Chemical Company (Dow), expected to close in the first half of 2017, creating a combined entity named DowDuPont.
- 2Post-merger plan to separate DowDuPont into three independent companies focused on agriculture, material science, and specialty products, intended to occur approximately 18 months after the merger.
- 32016 net sales were $24.6 billion, a slight decrease of 2% compared to 2015, driven by currency impacts and lower prices/product mix, though volume was flat.
- 4Successfully implemented a 2016 global cost savings and restructuring plan targeting $730 million in cost reductions compared to 2015.
- 5Continued significant investment in Research and Development, with $1.6 billion spent in 2016, focused on innovation across its diverse segments.
- 6Operates globally across six reportable segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials, and Protection Solutions, with 61% of sales outside the U.S. in 2016.
- 7Issued a significant amount of transaction-related costs ($386 million in 2016) associated with the planned merger and intended business separations.